Delivery ofcholesterol to inner mitochondrial membranes is rate-limiting for steroidogenesis in the zona fasciculata of adrenal cortex. A protein that stimulates this process was isolated to homogeneity from bovine adrenal tissue. This protein's primary structure has been determined in its entirety by a combination of automated Edman microsequencing, fast-atom bombardment mass spectrometry (FAB-MS). The sequence was identical to that previously reported for bovine brain endozepine, except that it lacks the last two residues, -Gly-Ile, at the C terminus. To our knowledge, isolation of an endozepine-related protein from a tissue other than brain has not been reported previously. Endozepine competes with benzodiazepines for saturable binding sites in synaptosomes and in mitochondria of specific peripheral tissues. Previous reports have localized the adrenal benzodiazepine receptor to the outer mitochondrial membrane. In this report, we show that the prototypic benzoiazepine, diazepam, effects a stimulation of adrenal mitochondrial cholesterol delivery similar to that observed for endozepine. The effective diazepam concentration was consistent with that previously shown to displace a high-affinity ligand of the mitochondrial benzodiazepine receptor. The action of diazepam in adrenal mitochondria suggests that the mediation of corticotropininduced steroidogenesis may be the physiological function of the peripheral-type benzodiazepine receptor. These studies provide new insights into the previously unknown function of peripheral benzodiazepine receptors and should allow new investigations into the stimulation of steroidogenesis by endozepines and benzodiazepines in the brain and in certain peripheral tissues.
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The rate of steroid synthesis in the adrenal cortex is controlled by the delivery of cholesterol from cytoplasmic inclusion droplets to the inner mitochondrial membrane, where steroidogenesis begins (1) (2) (3) . Cholesterol transport can conveniently be considered in two steps, both of which are accelerated in adrenocortical cells by corticotropin (ACTH). The first, transport to mitochondria, requires the action ofthe cytoskeleton and is independent of nascent protein synthesis (3) (4) (5) (6) . The second step is delivery from the outer to the inner mitochondrial membrane, which requires de novo protein synthesis induced by ACTH and its second messenger, cAMP (3, 7) . In the inner mitochondrial membrane, the first enzymatic reaction of steroidogenesis (i.e., the conversion of cholesterol to pregnenolone) is catalyzed by the cytochrome P450 side-chain cleavage enzyme.
Several cycloheximide-sensitive proteins that deliver cholesterol to the inner mitochondrial membrane and effect rapid change in the rate of adrenal steroidogenesis have been described (2, (8) (9) (10) . Steroidogenic activator peptides isolated from rat adrenal and rat Leydig cell tumor stimulate in vitro pregnenolone synthesis 1.6-to 17-fold, with half-maximal stimulation in the range of 10-100 nM (8, 9) .
More recently, a steroidogenic protein was isolated from bovine adrenal cortex (11) . This protein, provisionally designated "8.2K" in reference to its apparent molecular weight, stimulated cholesterol conversion to pregnenolone =3-fold and increased cholesterol delivery to the inner mitochondrial membrane, suggesting its potential importance in the modulation of steroidogenesis by ACTH (11) . The synthesis of this protein was stimulated by ACTH. Several of the proteins described above have been isolated to homogeneity but characterized only to a preliminary extent (e.g., amino acid composition, pI, molecular weight). Therefore we have undertaken the complete primary structural determination of this bovine adrenal steroidogenic protein (11) by using a combination of automated Edman microsequencing and fast-atom bombardment mass spectrometry (FAB-MS) of specific peptide fragments.
Since these studies revealed the relationship of this protein to bovine brain endozepine, we also briefly review here the biochemistry of benzodiazepine receptors and their ligands. y-Aminobutyric acid (GABAA)/benzodiazepine receptors in the central nervous system have been the object of considerable biochemical and pharmacological investigation (12, 13) . In contrast, peripheral-type benzodiazepine receptors have been detected in a number of tissues-for example, adrenal, testes, liver, and kidney (14, 15) . Some benzodiazepines {e.g., ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo [1,5a] ITo whom reprint requests should be addressed.
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Proteins that inhibit diazepam binding to synaptosomes have been isolated to homogeneity from bovine, human, and rat brains (19) (20) (21) (22) (23) (24) (25) . Although the peripheral expression of DBI proteins is established, their function in peripheral tissues remains a mystery.
In our structural investigation of the bovine adrenal steroidogenic protein (11), we have discovered its near identity to bovine brain endozepine. The data presented here will define the structural relationship between these two proteins and address the potential physiological function of this protein in the adrenal.
MATERIALS AND METHODS
Preparation of Mitochondria, Mitoplasts, and des-(GlyIle)-Endozepine. Mitochondria and mitoplasts were prepared as described (11, 26) . des-(Gly-Ile)-endozepine was isolated as reported (11) . Briefly, bovine adrenal zona fasciculata was homogenized, and the homogenate was chromatographed by carboxymethyl-cellulose ion-exchange, gel filtration, and reversed-phase high-performance liquid chromatography (HPLC). The stimulation of steroidogenesis by des-endozepine or diazepam was measured as described (11) .
Structural Characterization of Bovine Adrenal des-(Gly-Ile)-Endozepine. Protein to be employed for structural studies was rechromatographed by reversed-phase HPLC. Aliquots were hydrolyzed in 6 M HCl at 1150C for 24 hr, both with and without performic acid; hydrolysates were analyzed on a Beckman 6300 amino acid analyzer. One to 2 nmol of protein was digested with either HPLC-purified trypsin-L-1-tosylamido-2-phenylethyl chloromethyl ketone, 1:50 (wt/wt) (Worthington), or endoproteinase Asp-N, 1:40 (wt/wt) (Boehringer Mannheim), for 18 hr at 37TC. Peptides were collected after reversed-phase HPLC and subjected to analysis by automated Edman sequencing and FAB-MS.
Peptides and intact protein were spotted onto strips of poly(vinylidene difluoride) (Millipore) and sequenced on a gas-phase sequencer built at the City of Hope after the method of Hawke et al. (27) using the continuous-flow reactor modification of Shively et al. (28); phenylthiohydantoin amino acids were identified by using an on-line reversedphase HPLC system. Positive ion FAB-MS of peptides was performed according to Hefta et al. (29) . Dried peptide samples were dissolved in 5% acetic acid (vol/vol) and added to an equal volume of liquid matrix: dithiothreitol/dithioerythritol, 1:5 (wt/wt), containing 6 mM camphorsulfonic acid for tryptic peptides and thioglycerol for Asp-N peptides. Analysis was performed on a JEOL HX-100HF mass spectrometer operating at 5 kV accelerating potential and a nominal resolution of 3000; data were collected with a JEOL DA5000 data system. Calibration of the instrument was achieved by using a standard mixture of CsI/KI (30) . For B/E-linked FAB-MS of N-terminal peptides, the electricsector (E) voltage and magnetic-sector (B) field strength were linked to a constant ratio corresponding to transmission of the selected parent ion.
Measurement of Side-Chain Cleavage Stimulation. Pregnenolone formation was assayed essentially as described (11) . Bovine adrenal cortex tissue slices were enriched with cholesterol by incubation with 100 nM ACTH/1 mM cycloheximide for 30 min at 370C; subsequently, mitochondria were isolated by conventional methods (11) . Cholesterol delivery to the inner mitochondria membrane was monitored by its conversion to pregnenolone (11) . Pregnenolone was quantitated by thin-layer chromatography (11) . RESULTS A bovine adrenal protein that stimulated cholesterol delivery to mitochondria (previously designated as "8.2K" protein) was isolated from adrenal cortex as described (11) . Additional chromatography by reversed-phase HPLC indicated the presence of two closely eluting peaks that were present in relative ratios of -5:1 and were labeled peak A and peak B. respectively. Amino acid compositional analyses (data not shown) of the two proteins indicated that neither contained cysteine. This was in sharp contrast with other steroidogenic proteins characterized to date: the rat steroidogenic activator peptide of adrenal (8) and sterol carrier protein 2 (31) contained at least one residue per mol of cysteine.
Sequence analysis of peak A revealed that the protein was N-terminally blocked. However, peak B yielded a sequence found to be identical with bovine ubiquitin through 23 residues (32) . Since the amino acid compositions and molecular weights of peaks A and B are similar, it was not surprising that these two proteins copurified. Since the function of ubiquitin is the targeting of specific proteins for posttranslational modification and subsequent degradation (33) , it is unlikely to be involved in mitochondrial cholesterol transport. When peak B was tested in the cholesterol delivery assay system (11) , it was found to be devoid of steroidogenic activity. Thus, structural studies and investigation of cholesterol delivery to the mitochondrial membrane were focused on peak A.
Peak A was cleaved separately with trypsin and Asp-N proteases; the resulting peptide mixtures were resolved by reversed-phase HPLC (Fig. 1 ). Peptides were subsequently analyzed by FAB-MS and automated Edman microsequencing. In all cases, sequence and mass spectrometric data agreed to within 0.2 atomic mass unit (Table 1) . Through analysis of the tryptic peptide map by sequencing and FAB-MS, the sequence of peak A was aligned with that of brain endozepine. The monoisotopic masses obtained for the various peptides were sufficient to predict a high degree of homology between the two proteins.
Tryptic peptides T4 and T7 and Asp-N peptide N6 (Fig. 1 ) were found to be N-terminally blocked and presumed to be N-terminal peptides. After FAB-MS analysis, peptides N6 and T7 were subjected to B/E-linked FAB-MS; this procedure allows the selective examination of daughter ions derived from a parent ion (30) . As can be seen in Fig. 2 , fragmentation of N6 gave rise to several prominent ions. Of particular importance are the ions at 494 and 519 mass units that arise from the Y" and X series (34), respectively. These are consistent with the loss of an acetylserine moiety. Analysis of this spectrum and amino acid compositional data (not shown) allowed us to assign the sequence acetyl-SerGln-Ala-Glu-Phe to peptide N6. High nm.
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zyme cleaved before glutamic acid (at Glu-10, Glu-11, Glu-79); this is a previously unreported property of the enzyme. Sequence and mass spectrometric analysis of these peptides provided all of the remaining information needed to assemble the sequence of peak A in an unambiguous fashion. Most of the peptides analyzed by FAB-MS in our laboratory, including the tryptic peptides of peak A, have yielded detectable molecular ions in a matrix of dithiothreitol/dithioerythritol. However, it was observed that Asp-N peptides of peak A were refractory to analysis by FAB-MS with this matrix; interpretable data were obtained by using thioglycerol as the liquid matrix. The reasons for this difference are not clear at this time.
The sequence of peak A, shown in Fig. 3 , was found to be practically identical to that of bovine brain endozepine (20) , including the nature of the N-terminal blocking group. The sole difference between the two proteins was found at the C terminus, with peak A lacking the last two residues: -Gly-Ile. It is not possible to determine at this point whether the minor structural differences between peak A and endozepine are the result of in vivo posttranslational processing or reflect an artifact of isolation.
Since endozepine has been reported to bind to the peripheral-type benzodiazepine receptor of adrenal mitochondria (25) , which also binds various benzodiazepines, we have tested diazepam for steroidogenic activity. Diazepam stimulated pregnenolone formation in adrenal mitochondria (Fig.  4) in a concentration range (:10 ,uM) consistent with its binding affinity to the peripheral benzodiazepine receptor (20) . The dose-response curve is closely similar to that reported for the bovine adrenal steroidogenic protein (11).
DISCUSSION
We have previously reported the isolation of a protein from bovine adrenal zona fasciculata that stimulated cholesterol delivery to the inner mitochondrial membrane (11) . The synthesis of this protein was induced by ACTH, suggesting its importance in ACTH-induced steroidogenesis. In this report we have determined the primary structure of this protein in its entirety and identified it to be des-(Gly-Ile)-endozepine (also designated des-endozepine).
We have found that diazepam stimulates cholesterol delivery to the inner membrane of adrenal mitochondria to a similar extent as des-endozepine. This finding is of great significance since diazepam (17) and endozepine (25) bind to the adrenal benzodiazepine receptor of the outer mitochondrial membrane. Although the tissue distribution and biochemical properties of peripheral-type benzodiazepine receptors have been examined previously (14) (15) (16) (17) (18) Three successive scans were collected and averaged. The fragmentation of peptides is a complex process giving rise to a large collection of daughter ions whose origin can often be predicted. Some of these ions have been labeled in the mass spectra shown. To serve as a guide, the inset depicts predicted ions corresponding to distinct fragmentation series for the peptide; boxed numbers indicate ions actually observed in the mass spectra.
The presence of mRNA specific for DBI proteins has been demonstrated in a variety of tissues, including adrenal, testes, liver, and kidney (22) (23) (24) . Moreover, DBI immunoreactivity has been detected in the same tissues (21, 35) . However, DBI proteins have been previously isolated only from human, bovine, and rat brain (19) (20) (21) . Isolation of an endozepine-related protein from adrenal zona fasciculata has not been reported heretofore, confirming previous observations of message expression and immunoreactivity in this tissue.
The role of endozepine in the brain is not addressed in our studies. However, it should be noted that steroid production in the brain by mitochondrial cytochrome P450 side-chain
cleavage has been reported (36, 37) . The interaction of various steroids with the GABAA/benzodiazepine receptor has also been widely reported (38) (39) (40) . Thus, it is possible 1.0o
Complete sequence of adrenal des-(Gly-Ile)-endozepine (peak A). The amino acid sequence of peak A is shown above. The sequencing strategy employed is shown by the underlined regions; peptide fragments obtained from trypsin digestion are indicated below the residues, whereas Asp-N peptides are above. 
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Ml n that the steroidogenic activation effected by des-endozepine occurs in the brain as well as in the adrenal. Of particular significance is the observation that pregnenolone sulfate interacts with the GABAA/benzodiazepine receptor (39, 40) , and pregnenolone is the first product in the conversion of cholesterol to other steroids. Finally, the steroidogenic activities of diazepam and desendozepine in the adrenal are noteworthy in light of their possible mechanisms of action. Since delivery of cholesterol to the cytochrome P-450 side-chain cleavage enzyme is rate-limiting, measurements of steroidogenic activation are conveniently performed by using a spectral-shift assay, which monitors the ratio of substrate-to product-bound forms of the enzyme (11) . Addition of des-endozepine to mitochondria increased the substrate-bound fraction of the side-chain cleavage enzyme without addition of exogenous cholesterol (11) . This suggests that des-endozepine not only effects transport of cholesterol from the outer to inner mitochondrial membrane but may also assist in the mobilization of inner membrane cholesterol.
